This study tests a new drug called olorofim against a standard treatment (AmBisome followed by usual care) for a serious lung infection caused by Aspergillus fungus. About 225 adults with proven or probable infection will take part. The main goal is to see if olorofim reduces dea…
Phase: PHASE3 • Sponsor: F2G Biotech GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC